N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide dihydrochloride, 98.0%, 250mg

2-((2R,3R)-3-(TERT-BUTYL)-4-(3,5-DICYCLOPENTYL-2,6-DIMETHOXYPHENYL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOL-2-YL)PROPAN-2-OL, 95%, 50mg

5,6,7,8-Tetrahydronaphthalene-1-carbaldehyde, 95.0%, 1g

3-(3-chlorophenyl)-2-hydroxyprop-2-enoic acid, 98%, 100mg

4-Amino-2-methylpyrimidine-5-carboxylic acid, 97%, 5g

(S)-Methyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-aminohexanoate hydrochloride, 5g

4-Methyl-2-(trifluoromethyl)pyridine, 98%, 5g

2,6-Dimethylphenylboronic acid, 97.0%, 5g

4,6-Dichloro-3-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 500mg

4-isopropyl-5-methyl-4H-1,2,4-triazole-3-thiol, 250mg

(2R,3S)-1-[(tert-Butoxy)carbonyl]-3-methoxypyrrolidine-2-carboxylic acid, 97%, 250mg

{[4-(benzyloxy)phenyl]methyl}(propan-2-yl)amine, 95.0%, 2g

Methylcyclohexanol (2-,3-,4- and cis-,trans- mixture)>88.0%(GC)25mL